Skip to main content
Drug bottle and Pill

Compare Nesina vs. Byetta

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Alogliptin (Nesina) and exenatide (Byetta, Bydureon BCise) are both medications used to treat Type 2 diabetes, but they belong to different medication classes. Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps lower blood sugar by increasing insulin production in the body. Exenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps your body release insulin after eating and reduces the amount of sugar released from your liver. Alogliptin is taken orally once a day, while exenatide is injected under the skin (subcutaneously), with Byetta being a short-acting version taken twice daily and Bydureon BCise being a long-acting version taken once a week. Alogliptin and exenatide are available as both brand-name and lower-cost generic medications. Common side effects of alogliptin include headaches and cold-like symptoms, while exenatide can cause nausea, vomiting, and injection site reactions. Both medications can cause pancreatitis, but exenatide also carries a risk of thyroid cancer and kidney problems.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.